Rabpharma Designated as 2023 Guangdong Specialized, Sophisticated, Distinctive and Innovative SME
Rabpharma Closes Series A+ Round with Strategic Investors to Accelerate Oncology Pipeline
International Expert Symposium on Innovative Development of Bone Health Drugs & Enterprise Strategic Cooperation Agreement Signing Ceremony Successfully Held!
